COVID-19 Viral and Serology Testing in New York City Health Care Workers

Authors:

Abstract
While data continue to emerge around prevalence rates of coronavirus disease 2019 (COVID-19) in the general population, there is limited understanding of infection rates among health care workers (HCWs), a particularly important component of the response to this pandemic as more areas of the world experience surges in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates.1-3 Viral testing through reverse transcription polymerase chain reaction (RT-PCR) demonstrates active infection, whereas serologic testing for SARS-CoV-2 may answer epidemiologic questions about the prevalence of COVID-19, especially in areas where viral testing has been limited.4,5 Here we provide data showing SARS-CoV-2 antibody prevalence in HCWs working in a hospital in New York City (NYC) during the early pandemic in the United States.